Tech Company Financing Transactions
Signet Therapeutics Funding Round
On 11/2/2021, Signet Therapeutics raised $10 million in Seed financing from 5Y Capital, Blue Ocean Capital and Sky9 Capital.
Transaction Overview
Company Name
Announced On
11/2/2021
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Seed
Investors
Proceeds Purpose
The new funding will advance Signet's two first-in-class oncology programs toward clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
383 Langley Rd.
Newton, MA 02459
USA
Newton, MA 02459
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Developer of cancer therapies based on disease models intended to treat stomach and breast cancer. The company leverages disease models and artificial intelligence technology to develop cancer treatment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Haisheng Zhang
Browse more venture capital transactions:
Prev: 11/2/2021: OctoML venture capital transaction
Next: 11/2/2021: Zolve venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs